STRATA Skin Sciences presents TheraClear®X acne study at Maui Derm 2024

STRATA Skin Sciences, Inc.

Poster reports one treatment session using TheraClear®X with needle insert for cystic and papular acne.
Majority of lesions achieved ≥50% clearing by 1-2 weeks; average reduction score 3.5 (50-75% reduction).
Most frequent adverse event was mild hyperpigmentation; erythema, edema, flaking seen in ≤10% of lesions.
Conference takes place Jan 22-26, 2024 at Grand Wailea in Maui, Hawaii.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.